BACKGROUND: Apolipoprotein C3 (apo C3) is primarily secreted by the liver and is involved in promoting sterile inflammation and organ damage under pathological conditions. Previous studies have shown that apo C3 is abundant in the plasma exosomes of patients with aortic dissection (AD), but its specific role in AD remains unclear. METHODS AND RESULTS: In vivo, adeno-associated virus was used to knock down hepatic apo C3 expression in an AD mouse model to assess the impact of liver-derived apo C3 on the development of AD. In vitro, recombinant apo C3 protein was added to the culture medium of J774A.1 macrophages to evaluate its effect on macrophage polarization and to identify the underlying mechanisms. Additionally, the effect of apo C3 on the function of aortic endothelial and smooth muscle cells was explored. Apo C3 in the aortas of AD mice was found to originate from abnormal hepatic secretion, which enters the bloodstream and subsequently deposits in the aorta. Adeno-associated virus-mediated hepatic apo C3 knockdown significantly reduced AD incidence (P=0.0036), macrophage infiltration (P=0.0004), and collagen deposition in the aorta (P=0.0016). Similarly, inhibiting the apo C3 receptor Toll-like receptor 2 significantly lowered AD incidence (P=0.0352). In vitro, recombinant apo C3 protein promoted M1 polarization and matrix metalloproteinase secretion in macrophages by activating the Toll-like receptor 2/NLR family pyrin domain containing 3 pathway. Additionally, apo C3 increased adhesion molecule expression in endothelial cells and induced inflammation, chemotaxis, and apoptosis in vascular smooth muscle cells. CONCLUSIONS: Our findings highlight the role of abnormally secreted hepatic apo C3 in promoting aortic inflammation.
Hepatic Abnormal Secretion of Apolipoprotein C3 Promotes Inflammation in Aortic Dissection.
肝脏异常分泌载脂蛋白C3促进主动脉夹层炎症
阅读:5
作者:Zhuang Xinghui, Zarif Mohammad, Shen Yue, Zhang Zhaofeng, He Jian, Xie Linfeng, Wu Qingsong, Lin Xinfan, Chen Keyuan, Tian Yue, Lin Yong, Zhang Yuling, Cai Ziwen, Qiu Zhihuang, Chen Liangwan
| 期刊: | Journal of the American Heart Association | 影响因子: | 5.300 |
| 时间: | 2025 | 起止号: | 2025 Feb 4; 14(3):e037172 |
| doi: | 10.1161/JAHA.124.037172 | 研究方向: | 炎症/感染 |
| 疾病类型: | 肝炎 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
